Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney

American Journal of Physiology - Renal Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Simon, Matthias ^a   Maresh, John G ^a   Harris, Stephen E ^a   Hernandez, James D ^a   Arar, Mazen ^a   Olson, Merle S ^a   Abboud, Hanna E ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Cytokines; Differentiation; Growth factors; Metanephric mesenchyme; Transforming growth factor superfamily

Indexed keywords

CYTOKINE; GROWTH FACTOR; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; BONE MATRIX; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIUM CELL; IN SITU HYBRIDIZATION; KIDNEY ISCHEMIA; MESENCHYME CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REPERFUSION INJURY; RNA ANALYSIS;

EID: 0032922119     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.276.3.f382     Document Type: Article

References (41)

1. Almanzar, M. M., K. S. Frazier, P. H. Dube, A. I. Piqueras, W. K. Jones, M. F. Charette, and A. L. Paredes. Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury. J. Am. Soc. Nephrol. 9: 1456-1463, 1998.
2. Barnes, J. L., and H. A. Abboud. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in habu snake venom-induced glomerulonephritis. Am. J. Pathol. 143: 1366-1376, 1993.
3. Chevaile, A., B. C. Santos, S. Thies, and S. R. Gullans. BMP-9, a new member of the TGF-β superfamily, is expressed in the kidney and inhibits proliferation of mesangial and MDCK cells (Abstract). J. Am. Soc. Nephrol. 7: 1654, 1996.
4. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
5. Dorai, H., A. Shepard, J. Maliakal, H. Oppermann, S. Vukicevic, and T. K. Sampath. Osteogenic protein-1 (OP-1/ BMP-7) modulates smooth muscle cell growth and maintains the expression of cell phenotype and protects against cell injury mediated by nephrotoxic and inflammatory agents in vitro (Abstract). J. Am. Soc. Nephrol. 8: 297, 1997.
6. Dube, P., K. Frazier, M. Charette, and A. Paredes. Osteogenic protein-1 (rhOP-1) treatment induces tubular regeneration in the acute phase of the rat remnant kidney model (RRKM) (Abstract). J. Am. Soc. Nephrol. 8: 614, 1997.
7. Dudley, A. T., K. M. Lyons, and E. J. Robertson. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9: 2795-2807, 1995.
8. Edelstein, C. L., H. Ling, A. Wangsiripaisan, and R. W. Schrier. Emerging therapies for acute renal failure. Am. J. Kidney Dis. 30: S89-S95, 1997.
9. Harris, R. C. Growth factors and cytokines in acute renal failure. Adv. Ren. Replace. Ther. 4: 43-53, 1997.
10. Helder, M. N., E. Özkaynak, K. T. Sampath, F. P. Luyten, V. Latin, H. Oppermann, and S. Vukicevic. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J. Histochem. Cytochem. 43: 1035-1044, 1995.
11. Herzlinger, D., C. Koseki, T. Mikawa, and Q. Al-Awqati. Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction. Development 114: 565-572, 1992.
12. Huggins, C. B. The formation of bone under the influence of epithelium of the urinary tract. Arch. Surg. 22: 377-408, 1931.
13. Jones, C. M., K. M. Lyons, and B. L. Hogan. Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 111: 531-542, 1991.
14. Kelly, K. J., and J. V. Bonventre. Osteogenic protein-1 protects the rat kidney from ischemic injury (Abstract). J. Am. Soc. Nephrol. 7: 1827, 1996.
15. Kim, Y.-S., S. Harris, J. Wozney, and H. E. Abboud. Effect of bone morphogenetic protein-2 (BMP-2) on mesangial cell growth and migration: role of protein kinase C (Abstract). J. Am. Soc. Nephrol. 7: 1660, 1996.
16. Knittel, T., P. Fellmer, L. Muller, and G. Ramadori. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Exp. Cell Res. 232: 263-269, 1997.
17. Luo, G., C. Hofmann, A. L. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9: 2808-2820, 1995.
18. Lyons, K. M., B. L. Hogan, and E. J. Robertson. Colocalization of BMP 7 and BMP 2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech. Dev. 50: 71-83, 1995.
19. Lyons, K. M., C. M. Jones, and B. L. Hogan. The DVR gene family in embryonic development. Trends Genet. 7: 408-412, 1991.
20. Lyons, K. M., R. W. Pelton, and B. L. Hogan. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109: 833-844, 1990.
21. Lyons, K. M., R. W. Pelton, and B. L. Hogan. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev. 3: 1657-1668, 1989.
22. Massaque, J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6: 597-641, 1990.
23. Molitoris, B. A. Cellular basis of ischemic acute renal failure. In: Acute Renal Failure (3rd ed.), edited by J. M. Lazarus and B. M. Brenner. New York: Churchill Livingstone, 1993, p. 1-32.
24. Nakaoka, T., K. Gonda, T. Ogita, Y. Otawara-Hamamoto, F. Okabe, Y. Kira, K. Harii, K. Miyazono, Y. Takuwa, and T. Fujita. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J. Clin. Invest. 100: 2824-2832, 1997.
25. Özkaynak, E., P. N. Schnegelsberg, D. F. Jin, G. M. Clifford, F. D. Warren, E. A. Drier, and H. Oppermann. Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J. Biol. Chem. 267: 25220-25227, 1992.
26. Özkaynak, E., P. N. Schnegelsberg, and H. Oppermann. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem. Biophys. Res. Commun. 179: 116-123, 1991.
27. Sampath, T. K., and A. H. Reddi. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl. Acad. Sci. USA 78: 7599-7603, 1981.
28. Simon, M., H.-J. Gröne, O. Jöhren, J. Kullmer, K. H. Plate, W. Risau, and E. Fuchs. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F240-F250, 1995.
29. Solez, K. The morphology of acute renal failure. In: Acute Renal Failure, edited by J. M. Lazarus and B. M. Brenner. New York: Churchill Livingstone, 1993, p. 33-52.
30. Sporn, M. B., and A. B. Roberts. Transforming growth factor-beta: recent progress and new challenges. J. Cell Biol. 119: 1017-1021, 1992.
31. Suzuki, A., S. Nishimatsu, K. Murakami, and N. Ueno. Differential expression of Xenopus BMPs in early embryos and tissues. Zoolog. Sci. 10: 175-178, 1993.
32. Takahashi, H., and T. Ikeda. Transcripts for two members of the transforming growth factor-beta superfamily BMP-3 and BMP-7 are expressed in developing rat embryos. Dev. Dyn. 207: 439-449, 1996.
33. Urist, M. R. Bone: formation by autoinduction. Science 150: 893-899, 1965.
34. Urist, M. R., Y. K. Huo, A. G. Brownell, W. M. Hohl, J. Buyske, A. Lietze, P. Tempst, M. Hunkapiller, and R. J. DeLange. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc. Natl. Acad. Sci. USA 81: 371-375, 1984.
35. Vukicevic, S., V. Basic, D. Rogic, N. Basic, M.-S. Shih, A. Shepard, D. Jin, B. Dattatreyamurty, W. Jones, H. Dorai, S. Ryan, D. Griffiths, J. Maliakal, M. Jelic, M. Pastorcic, A. Stavljcnic, and T. K. Sampath. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J. Clin. Invest. 102: 202-214, 1998.
36. Vukicevic, S., M. Grgic, A. Stavijenic, and T. K. Sampath. Recombinant human OP-1 (BMP-7) prevents rapid loss of glomerular function and improves mortality associated with chronic renal failure (Abstract). J. Am. Soc. Nephrol. 7: 1867, 1996.
37. Vukicevic, S., M. N. Helder, and F. P. Luyten. Developing human lung and kidney are major sites for synthesis of bone morphogenetic protein-3 (osteogenin). J. Histochem. Cytochem. 42: 869-875, 1994.
38. Vukicevic, S., J. B. Kopp, F. P. Luyten, and T. K. Sampath. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc. Natl. Acad. Sci. USA 93: 9021-9026, 1996.
39. Vukicevic, S., V. Latin, P. Chen, R. Batorsky, A. H. Reddi, and T. K. Sampath. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem. Biophys. Res. Commun. 198: 693-700, 1994.
40. Wozney, J. M., V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, and E. A. Wang. Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534, 1988.
41. Ying, S. Y. Inhibins, activins, and follistatins. J. Steroid Biochem. 33: 705-713, 1989.